Australia's largest stock trading and investment forum Australia's #1 stock forum

AVH

4.97%

$3.06 avita medical inc.

Ann: AVITA Medical to Announce First Quarter 2023 Results, page-7

First 7 Last

Share
Profile

Follow
keepsmiling

4,214 Posts.

311

11/05/23

10:53

Post #: 67717548
Share
Originally posted by saltland: ↑

That makes sense, it was a pretty dumb question! I agree that it will be interesting when comparing them to the company's past performance and guidance:

Q123 commercial revenue guidance of US$10-11 million = 34-48% growth on Q122
Revenue guidance update for Q223 (similar growth to Q123 = $11-12m?) and FY23
Expenses for R&D and commercial expansion are expected to peak in Q323 (% basis compared to revenue) and decline notably afterwards. Just my thoughts: Even though expenses will be increasing, I think the loss for Q123 will be less than Q122 but it will probably be more than the $5.4 million loss for Q422 e.g. net loss decreased by 45% to $6.5 million compared to a net loss of $9.5 million for the same period in 2022.
“Setting guidance isn’t an exercise in sandbagging. It’s an exercise in credibility and very different to what has been done before” - J.C.

I also find the webcasts interesting because we normally get additional company insights and updates, feel free to tune in if you get a chance:
https://ir.avitamedical.com/events/event-details/avita-medical-inc-first-quarter-2023-earnings-conference-call

In saying all that, there's a part of me that thinks you meant it'll be interesting to compare the revenue growth and quarterly loss to that of another company

Expand

Its seems that revenue/sales is circa us$10.3m. Probably par result not exceptional.
AVH Price at posting: $4.81 Sentiment: None Disclosure: Not Held
Upvote

0 Great analysis

Reply

Top Stories

SWP

Swoop lobs $18M offer at microcap telecom Vonex – in which it holds 19.9%

TLG

Talga Group wins key permit for flagship graphite mine in Sweden

MTH

Mithril's drilling in Mexico picks up silver at 997g/t, gold at 28g/t

M4M

Macro, Norden set up transport solutions initiative for West Pilbara

IRX

InhaleRX snags $38.5M in funding from VC biotech funder Clendon

MKT

The ASX can overlook its Telecomm small-caps. Here’s one diversified brand with an international footprint

SNX

Sierra Nevada raises $2M for silver exploration at Blackhawk

What's causing the cost-of-living crisis, and how to navigate it

Week 42 Wrap: HotCopper's top picks; new ASX 200 record; world yawns at war

NVU

Nanoveu surges 10% after benchmark testing for new AI chip begins